Cargando…

Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report

Currently, there are no sensitive diagnostic tests that could allow early detection of lung cancer. Among some cancer patients, epigenetic changes in the nature of methylation of different gene promoter regions are observed, which affect expression of suppressor genes such as septin 9 (SEPT9). Due t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Powrózek, Tomasz, Krawczyk, Paweł, Kucharczyk, Tomasz, Milanowski, Janusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971444/ https://www.ncbi.nlm.nih.gov/pubmed/24633736 http://dx.doi.org/10.1007/s12032-014-0917-4

Ejemplares similares

Letter to the editor concerning first-line therapy with afatinib – an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations
por: Krawczyk, Paweł, et al.
Publicado: (2015)

Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer
por: Krawczyk, Paweł, et al.
Publicado: (2017)

Circulating methylated Septin 9 and ring finger protein 180 for noninvasive diagnosis of early gastric cancer
por: Cao, Chang-Qi, et al.
Publicado: (2020)

Sensitive methods for detection of the S768R substitution in exon 18 of the DDR2 gene in patients with central nervous system metastases of non-small cell lung cancer
por: Nicoś, Marcin, et al.
Publicado: (2014)

Sensitive methods for the detection of an insertion in exon 20 of the HER2 gene in the metastasis of non-small cell lung cancer to the central nervous system
por: KRAWCZYK, PAWEŁ, et al.
Publicado: (2013)

Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer
por: Krawczyk, Paweł, et al.
Publicado: (2012)

The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients
por: Kucharczyk, Tomasz, et al.
Publicado: (2015)

The Application of Real-Time PCR Technique to Detect Rare Cell Clones with Primary T790M Substitution of EGFR Gene in Metastases of Non-small Cell Lung Cancer to Central Nervous System in Chemotherapy Naive Patients
por: Powrózek, Tomasz, et al.
Publicado: (2014)

Immunotherapy in Non-Small-Cell Lung Cancer Patients with Driver Alterations: A New Strategy?
por: Krzyżanowska, Natalia, et al.
Publicado: (2022)

The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings
por: Kieszko, Robert, et al.
Publicado: (2015)

Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
por: Fu, Bo, et al.
Publicado: (2018)

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients
por: Krawczyk, Paweł, et al.
Publicado: (2014)

Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2016)

Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine
por: Mlak, Radosław, et al.
Publicado: (2018)

Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine
por: Mlak, Radosław, et al.
Publicado: (2015)

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
por: Krawczyk, Paweł, et al.
Publicado: (2013)

Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy
por: Wojas-Krawczyk, Kamila, et al.
Publicado: (2021)

Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA
por: Tóth, Kinga, et al.
Publicado: (2014)

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes
por: Krawczyk, Paweł, et al.
Publicado: (2017)

Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer
por: Lu, Pingxia, et al.
Publicado: (2022)

Impact of I/D polymorphism of ACE gene on risk of development and course of chronic obstructive pulmonary disease
por: Mlak, Radosław, et al.
Publicado: (2016)

In vitro preliminary study on different anti-PD-1 antibody concentrations on T cells activation
por: Wieleba, Irena, et al.
Publicado: (2022)

Diagnostic Value of Methylated Septin9 for Colorectal Cancer Detection
por: Xie, Li, et al.
Publicado: (2018)

EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report
por: Kamila, Wojas-Krawczyk, et al.
Publicado: (2013)

Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer
por: Nicoś, Marcin, et al.
Publicado: (2017)

Methylated Septin 9 and Carcinoembryonic Antigen for Serological Diagnosis and Monitoring of Patients with Colorectal Cancer After Surgery
por: Ma, Zhi Yao, et al.
Publicado: (2019)

Combining methylated SEPTIN9 and RNF180 plasma markers for diagnosis and early detection of gastric cancer
por: Nie, Yongzhan, et al.
Publicado: (2023)

HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery
por: Grenda, Anna, et al.
Publicado: (2020)

Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement
por: Krawczyk, Paweł, et al.
Publicado: (2021)

Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer
por: Powrózek, Tomasz, et al.
Publicado: (2022)

Dual-modality loop-mediated isothermal amplification for pretreatment-free detection of Septin9 methylated DNA in colorectal cancer
por: Lin, Qiuyuan, et al.
Publicado: (2021)

Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients
por: Yang, Xue, et al.
Publicado: (2019)

Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer
por: Nicoś, Marcin, et al.
Publicado: (2015)

Methylation of DROSHA and DICER as a Biomarker for the Detection of Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2021)

Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells
por: Xu, Dongchao, et al.
Publicado: (2018)

Detection of Methylated Circulating DNA as Noninvasive Biomarkers for Breast Cancer Diagnosis
por: Cheuk, Isabella Wai Yin, et al.
Publicado: (2017)

Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer
por: Zhao, Luyao, et al.
Publicado: (2022)

Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
por: Grützmann, Robert, et al.
Publicado: (2008)

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
por: Warren, Jorja D, et al.
Publicado: (2011)

Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis
por: Yan, Shirong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_54at4ggsccike5ii1ueeip9me6